Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphentin Time Course Response in Children with ADHD
NCT01269463Phase 3Completed
- Sponsor
- Rhodes Pharmaceuticals
- Start
- Jan 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Rhodes Pharmaceuticals. Started Jan 2011; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01269463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269463.